Back to top
more

BioLineRx (BLRX)

(Delayed Data from NSDQ)

$3.17 USD

3.17
6,024

+0.05 (1.61%)

Updated Jun 26, 2026 03:59 PM ET

After-Market: $3.20 +0.04 (1.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:
Message not found:17303

NA Value NA Growth NA Momentum NA VGM

Industry Rank:
Message not found:17304

Top 44% (108 out of 245)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Fundamental Charts

About Total Assets (Quarterly)

The company's quarterly Total Assets is the company's net worth. It is the current quarter's sum of current and long-term assets; cash, investments, real estate, equipment, receivables and other intangibles.

BLRX 3.17 +0.05(1.61%)

Will BLRX be a Portfolio Killer in June?

Zacks Investment Research is releasing its prediction for BLRX based on the 1-3 month trading system that more than doubles the S&P 500.

Click here - the BLRX analysis is free »

Other News for BLRX